AUB ScholarWorks
Value creation in pharmaceutical mergers and acquisitions - by Amer Haitham Haddadin
JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | Haddadin, Amer Haitham |
| dc.date.accessioned | 2012-06-13T07:08:25Z |
| dc.date.available | 2012-06-13T07:08:25Z |
| dc.date.issued | 2004 |
| dc.identifier.uri | http://hdl.handle.net/10938/6728 |
| dc.description | Project (M.B.A.)--Suliman S. Olayan School of Business, AUB, 2004. |
| dc.description | Bibliography: leaves 35-36. |
| dc.description.abstract | This project demonstrates the changing nature of the pharmaceutical industry and how these changes have led to value- creating horizontal mergers using sampl e of the main pharmaceutical mergers and acquisitions completed during the period Oct ober 1989 t |
| dc.format.extent | ix, 36 leaves 30 cm. |
| dc.language.iso | eng |
| dc.relation.ispartof | Theses, Dissertations, and Projects |
| dc.subject.classification | Pj:001213 AUBNO |
| dc.subject.lcsh | Pharmaceutical industry |
| dc.subject.lcsh | Cash flow |
| dc.title | Value creation in pharmaceutical mergers and acquisitions - by Amer Haitham Haddadin |
| dc.type | Student Project |
| dc.contributor.department | School of Business |
| dc.contributor.faculty | Suliman S. Olayan School of Business |
| dc.contributor.institution | American University of Beirut |
